Hofheinz, R., & Lorenzen, S. (2015). Ramucirumab as second-line treatment for patients with metastatic esophagogastric adenocarcinoma. Expert review of anticancer therapy, 15(6), . https://doi.org/10.1586/14737140.2015.1052412
Chicago-Zitierstil (17. Ausg.)Hofheinz, Ralf-Dieter, und Sylvie Lorenzen. "Ramucirumab as Second-line Treatment for Patients with Metastatic Esophagogastric Adenocarcinoma." Expert Review of Anticancer Therapy 15, no. 6 (2015). https://doi.org/10.1586/14737140.2015.1052412.
MLA-Zitierstil (9. Ausg.)Hofheinz, Ralf-Dieter, und Sylvie Lorenzen. "Ramucirumab as Second-line Treatment for Patients with Metastatic Esophagogastric Adenocarcinoma." Expert Review of Anticancer Therapy, vol. 15, no. 6, 2015, https://doi.org/10.1586/14737140.2015.1052412.